Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB1C, also known as Putative Ras-related protein Rab-1C, is a pseudogene in humans and is not known to encode a functional protein[1][5]. Although it is annotated as a putative member of the Rab GTPase family, multiple reputable sources classify it specifically as a pseudogene, indicating that it does not produce a biologically active target for pharmacological intervention[1][5]. As a pseudogene, RAB1C lacks known molecular or cellular function, disease association, and does not serve as a druggable target in current biomedical literature[5][4]. **Key notes:** - This entry appears to refer to a pseudogene, not a functional protein-coding gene or therapeutic target[1][5]. - "Rab-1C" in the human genome is widely annotated as non-protein coding (pseudogene), hence it cannot be considered a typical therapeutic target[1][5]. - No drugs or disease associations are reported for this entity. - If you intended to refer to a functional Rab protein (such as Rab1A or Rab1B, which are known to function in ER-to-Golgi transport and vesicle trafficking[2]), please clarify for more targeted and relevant information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Putative Ras-related protein Rab-1C (RAB1C).